Evidence map›Paper›PMID 27920516›Full record

Trial reportInternational journal of chronic obstructive pulmonary disease2016

Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: a cluster randomized trial.

Kris Vanhaecht, Cathy Lodewijckx, Walter Sermeus, Marc Decramer, Svin Deneckere, Fabrizio Leigheb, Paulo Boto, Seval Kul, Deborah Seys, Massimiliano Panella

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in International journal of chronic obstructive pulmonary disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Impact of an Inpatient COPD Care Pathway on Hospital Care Process and Outcome Metrics.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Reducing the Number of Hospitalization Days for COPD: Setting up a Transmural-Care Pathway.International journal of chronic obstructive pulmonary disease · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kris VanhaechtDepartment of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven - University of Leuven; Department of Quality Management, University Hospitals Leuven.
Cathy LodewijckxDepartment of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven - University of Leuven.
Walter SermeusDepartment of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven - University of Leuven.
Marc DecramerDepartment of Clinical and Experimental Medicine, KU Leuven - University of Leuven; University Hospitals Leuven, Leuven.
Svin DeneckereDepartment of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven - University of Leuven; Medical Department, Delta Hospitals Roeselare, Roeselare, Belgium.
Fabrizio LeighebDepartment of Translational Medicine, University of Eastern Piedmont, Vercelli, Italy.
Paulo BotoDepartment of Health Services Policy and Management, Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisbon, Portugal.
Seval KulDepartment of Biostatistics, School of Medicine, University of Gaziantep, Gaziantep, Turkey.
Deborah SeysDepartment of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven - University of Leuven.
Massimiliano PanellaDepartment of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven - University of Leuven; Department of Translational Medicine, University of Eastern Piedmont, Vercelli, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCurrent in-hospital management of exacerbations of COPD is suboptimal, and patient outcomes are poor. The primary aim of this study was to evaluate whether implementation of a care pathway (CP) for COPD improves the 6 months readmission rate. Secondary outcomes were the 30 days readmission rate, mortality, length of stay and adherence to guidelines. PATIENTS AND

methodsAn international cluster randomized controlled trial was performed in Belgium, Italy and Portugal. General hospitals were randomly assigned to an intervention group where a CP was implemented or a control group where usual care was provided. The targeted population included patients with COPD exacerbation.

resultsTwenty-two hospitals were included, whereof 11 hospitals (n=174 patients) were randomized to the intervention group and 11 hospitals (n=168 patients) to the control group. The CP had no impact on the 6 months readmission rate. However, the 30 days readmission rate was significantly lower in the intervention group (9.7%; 15/155) compared to the control group (15.3%; 22/144) (odds ratio =0.427; 95% confidence interval 0.222-0.822;

conclusionThe implementation of this in-hospital CP for COPD exacerbation has no impact on the 6 months readmission rate, but it significantly reduces the 30 days readmission rate.

Indexed as

AgedAged, 80 and overChi-Square DistributionCluster AnalysisCritical PathwaysEuropeFemaleGuideline AdherenceHumansLength of StayLinear ModelsLogistic ModelsLungMaleMiddle AgedOdds Ratiocare pathwaycluster randomized controlled trialCOPDquality improvementreadmission

Identifiers

PMID27920516
PMCPMC5126002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.